Search

everythinglearnresearchcommunity

for

Search:↓

Combining multiple algorithms predicts hair fall more accurately than using single algorithms.

ADSC-Exos with miR-122-5p can help treat hair loss by promoting hair growth.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Fat from the body can help improve hair growth and scars when used in skin treatments.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

A portable device can create nanofibers to improve the appearance of thinning hair better than commercial products.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Cell-based models help test if cosmetic ingredients really work for hair growth and skin health.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Minoxidil modestly increases hair growth in men with early baldness and is safe to use.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

Karaviradya taila reduces hair growth and hair follicles.

Micrografts are useful for healing wounds, regenerating bone and periodontal tissues, and improving hair transplantation outcomes.